Transcription of RECENT MAJOR CHANGES - novo-pi.com
{{id}} {{{paragraph}}}
Example: dental hygienist
RECENT MAJOR CHANGES - novo-pi.com
1 HIGHLIGHTS OF PRESCRIBING INFORMATIONT hese highlights do not include all the information needed to use TRESIBA safely and effectively. See full prescribing information for TRESIBA .TRESIBA (insulin degludec injection), for subcutaneous use Initial Approval: 2015 RECENT MAJOR CHANGES Dosage and Administration ( ) 11/2018 Warnings and Precautions ( ) 11/2018 INDICATIONS AND USAGE TRESIBA is a long-acting human insulin analog indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus (1).Limitations of Use: Not recommended for treating diabetic ketoacidosis.
TRESIBA ® (insulin degludec necton) 2 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE TRESIBA® is indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus. Limitations of Use • Not recommended for the treatment of diabetic ketoacidosis.
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: